Saturday 17 October 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025. In the quarter to June 2026, revenue grew 1.71%, EPS fell 4.35%, free cash flow fell 95.6% and total debt fell 2.58%, each against the same quarter a year earlier.

19.67 0.22 +1.13%

Follow TAK

Alert me

Market cap: $61.9B
P/E: 29.6×
Fwd P/E: —
Dividend yield: 1.57%
F-score: 4/9
Altman Z: 1.03
Beneish M: −2.65
Dividend safety: 25/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Jun '25	Sep '25	Dec '25	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	7	—	—	6
ROE Full definition →		4.39%	0.00%	0.00%	4.42%
ROA Full definition →		2.13%	0.00%	0.00%	2.15%
ROIC Full definition →		2.42%	0.00%	0.00%	2.88%
Return on Tangible Assets Full definition →		13.48%	0.00%	0.00%	13.40%
Average Days of Receivables Full definition →		57.31	0.00	0.00	73.31
Free Cash Flow per Share Full definition →		2.02	0.00	0.00	2.35
Free Cash Flow Full definition →		6,324.44	8,314.41	10,878.22	7,420.86
Capital Expenditures Full definition →		(3,696.62)	(3,167.12)	(4,954.63)	(3,704.87)
Other line items
Cash ROIC Full definition →		7.77%	9.77%	12.62%	9.04%
Accounts Receivable Turnover Full definition →		6.29	0.00	0.00	5.52
Accounts Payable Turnover Full definition →		3.07	0.00	0.00	3.50
Inventory Turnover Full definition →		1.21	0.00	0.00	1.18
Average Days of Payables Full definition →		103.42	0.00	0.00	100.31
Days of Inventory on Hand Full definition →		304.55	0.00	0.00	324.95
Tax Rate Full definition →		0.10	—	—	(0.17)
Research and Development Expense of Revenue Full definition →		15.57%	—	—	14.77%
Selling, General and Administrative Expense of Revenue Full definition →		24.14%	—	—	23.99%
Share Based Compensation of Revenue Full definition →		2.43%	0.00%	0.00%	2.33%
Interest Coverage Full definition →		1.62	—	—	1.99
Operating CF/Net income Full definition →		4.68	0.00	0.00	5.21
Depreciation/Fixed assets Full definition →		0.56	0.56	0.73	0.53
Capex/Depreciation Full definition →		(0.49)	(0.42)	(0.50)	(0.52)
Revenue per Share Full definition →		9.54	—	—	9.49
Operating CF per Share Full definition →		3.20	0.00	0.00	3.52
Capex per Share Full definition →		(1.18)	0.00	0.00	(1.17)
Capex to Sales Full definition →		0.12	0.00	0.00	0.12

Show all line items

Columns are period end dates

Stockrow Weekly